INSYS Therapeutics Inc. (NASDAQ:INSY) and Cara Therapeutics Inc. (NASDAQ:CARA) are two firms in the Biotechnology that compete against each other. Below is a comparison of their risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership.
Valuation and Earnings
Table 1 highlights INSYS Therapeutics Inc. and Cara Therapeutics Inc.’s gross revenue, earnings per share (EPS) and valuation.
Table 2 represents INSYS Therapeutics Inc. (NASDAQ:INSY) and Cara Therapeutics Inc. (NASDAQ:CARA)’s return on equity, net margins and return on assets.
Volatility and Risk
A beta of 2.56 shows that INSYS Therapeutics Inc. is 156.00% more volatile than Standard Poor’s 500. Cara Therapeutics Inc. has a 2.71 beta and it is 171.00% more volatile than Standard Poor’s 500.
INSYS Therapeutics Inc. has a Current Ratio of 0.7 and a Quick Ratio of 0.6. Competitively, Cara Therapeutics Inc.’s Current Ratio is 4.9 and has 4.9 Quick Ratio.